Following the continued success of New Horizons in Cardiomyopathy (NHC) in 2025, Radcliffe Cardiology is delighted to return with the next edition on Tuesday 26 and Wednesday 27 May 2026.
The event will offer an engaging and interactive platform for healthcare professionals to stay up to date on the diagnosis and management of cardiac amyloidosis and cardiomyopathy.
Across the two days, the programme will feature expert-led sessions covering key developments in cardiomyopathy and cardiac amyloidosis. Attendees can expect in-depth discussions on disease mechanisms, current best practices, diagnostic strategies, real-world case discussions and the latest therapeutic innovations, all designed to support clinical decision-making and improve patient outcomes.
The course directors, Dr Rodney Falk (Brigham and Women's Hospital, Boston, US), Dr Margot Davis (Vancouver General Hospital, Vancouver, CA) and Prof Iacopo Olivotto (Careggi University Hospital, Florence, IT) will lead the event and bring together a distinguished group of faculty members who are renowned experts. Their combined knowledge will provide attendees with a well-rounded, collaborative learning experience.
Register now to stay at the forefront of innovation in cardiomyopathy and cardiac amyloidosis. We look forward to welcoming you to New Horizons in Cardiomyopathy 2026.
*New Horizons in Cardiomyopathy 2026's programme will be submitted to the European Board for Accreditation of Continuing Education for Health Professionals (EBAC).
(Please note this programme is subject to change)
Day 1 - Focus on Cardiomyopathy
Session 1.1: Sonography 101 – diagnosing and monitoring cardiomyopathies
Chair: Rodney Falk (Boston, US)
Panel: Elena Arbelo (Barcelona, ES); Ahmad Masri (Portland, US)
Challenging patient case: mixed symptoms suggestive of cardiomyopathy; X-ray confirmed cardiac aetiology) - Rodney Falk
Echocardiography results presented
Audience polling: most likely diagnosis based on echo features; what next?
Echocardiography workshop 1: HCM - Elena Arbelo
Echocardiography workshop 2: Cardiac Amyloidosis - Ahmad Masri
Audience Q&A - All
Session 1.2: CT, CMR and nuclear imaging in diagnosis and monitoring
Chair: Margot Davis (Vancouver, CA)
Panel: Arnt Kristen (Darmstadt, DE); Olivier Lairez (Toulouse, FR)
CT workshop
CMR workshop
Nuclear imaging: What cardiologists need to know
Audience Q&A
Session 1.3: Case conclusion
Chair: Rodney Falk (Boston, US)
Panel: Elena Arbelo (Barcelona, ES); Ahmad Masri (Portland, US)
Case conclusion
Discussion and faculty Q&A - All
Session 1.4: Future of imaging in cardiomyopathy
Chair: Margot Davis (Vancouver, CA)
Panel: Sharmila Dorbala (Boston, US); Iacopo Olivotto (Florence, IT)
Unmet needs of imaging in diagnosis and monitoring - Sharmila Dorbala
Assessing the impact of AI - Sharmila Dorbala
Imaging in HCM - Iacopo Olivotto
Monitoring and risk stratification
Future/ongoing trials
Audience Q&A
Day 2 - Focus on Amyloidosis
Session 2.1: Advances in cardiomyopathy: Clinical trial updates
Chair: Rodney Falk (Boston, US)
Panel: Esther Gonzalez Lopez (Madrid, ES); Ahmad Masri (Portland, US); Fabian Knebel (Berlin, DE)
Disease-modifying treatments in ATTR and AL - Esther Gonzalez Lopez
Advances in HCM (obstructive and non-obstructive) - Ahmad Masri
Emerging prognostic biomarkers - Fabian Knebel
Audience Q&A - All
Session 2.2: Personalising treatment in amyloidosis
Chair: Margot Davis (Vancouver, CA)
Panel: Joao Agostinho (Lisbon, PT); Ahmad Masri (Portland, US)
Optimising treatment in ATTR: Sequencing therapies and biomarkers - Joao Agostinho
Sequencing therapies in ATTR
Biomarkers and surrogate endpoints in amyloidosis research
Disparities in clinical trials: gap between race and gender - Margot Davis
Gaps in guidelines; gaps in evidence: new guideline development - Ahmad Masri
Audience Q&A - All
Session 2.3: HCM and comorbidity management
Chair: Iacopo Olivotto (Florence, IT)
Panel: Alessia Argiro (Florence, IT); Juan Pablo Kaski (London, UK)
Common HCM phenocopies - Alessia Argiro
Genetics of HCM
Managing HCM in the young - Juan Pablo Kaski
Audience Q&A - All
Margot Davis
Course Director
University of British Columbia, Vancouver, CA
more info
Rodney Falk
Course Director
Brigham and Women's Hospital, Boston, US
more info
Iacopo Olivotto
Course Director
Careggi University Hospital, Florence, IT
more info
Increase the awareness of at-risk patients
Improve understanding of screening procedures
Provide guidance on the use of imaging for diagnosis
Improve awareness on current and emerging treatment
Provide guidance on initiating treatment and managing comorbidities
If you're interested in becoming a partner at NHC, please contact sales@radcliffe-group.com
Official Journal
Cardiac Failure Review (CFR) is an international, English language, peer-reviewed journal that publishes articles continually to CFRjournal.com and aims to assist time-pressured physicians to stay abreast of key advances and opinion in the area of heart failure.
The journal comprises balanced and comprehensive review articles and original research written by leading authorities. The journal provides updates on a range of salient issues to support physicians in developing their knowledge and effectiveness in day-to-day clinical practice.
The journal endeavours to support the continuous medical education of specialist and general cardiologists and disseminate knowledge of the field to the wider cardiovascular community.
Partnership: CFR is the official journal of the Italian Heart Failure Association (ITAHFA).
Journal website: www.cfrjournal.com
About Radcliffe Cardiology
We are Radcliffe, a knowledge network for the cardiovascular community We’re here to bring cardiovascular knowledge, insight and innovation to life for clinicians around the world, using our communications and creative expertise, our platforms and connections across the community to help transform theory into practice faster and more effectively. We bring medical knowledge to life From great science writing and smart journal editing, the curation of evidence based and peer-reviewed content, to engaging new formats that cut through the noise, we believe that communication is at the heart of great healthcare. Our work is underpinned by 3 core principles:
We build on the best science
We work hands-on with our community
We bring fresh thinking
Our promise is that we’ll equip you with the latest knowledge and skills you need, to do the best for your patients. For more information on Radcliffe Cardiology, please visit www.radcliffecardiology.com